Trade Evotec AG - EVT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.040 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.018641% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.003582% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Germany | ||||||||
| Commission on trade | 0% |
| Prev. Close | 8.495 |
| Open | 8.645 |
| 1-Year Change | -36.78% |
| Day's Range | 8.405 - 8.67 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 8.470 | -0.110 | -1.28% | 8.580 | 8.675 | 8.375 |
| Feb 20, 2025 | 8.495 | -0.090 | -1.05% | 8.585 | 8.770 | 8.435 |
| Feb 19, 2025 | 8.530 | -0.240 | -2.74% | 8.770 | 8.930 | 8.275 |
| Feb 18, 2025 | 8.870 | 0.215 | 2.48% | 8.655 | 9.010 | 8.530 |
| Feb 17, 2025 | 8.680 | -0.005 | -0.06% | 8.685 | 8.750 | 8.310 |
| Feb 14, 2025 | 8.710 | -0.020 | -0.23% | 8.730 | 8.920 | 8.670 |
| Feb 13, 2025 | 8.780 | 0.290 | 3.42% | 8.490 | 8.890 | 8.490 |
| Feb 12, 2025 | 8.440 | -0.015 | -0.18% | 8.455 | 8.545 | 8.130 |
| Feb 11, 2025 | 8.465 | -0.245 | -2.81% | 8.710 | 8.720 | 8.330 |
| Feb 10, 2025 | 8.730 | 0.050 | 0.58% | 8.680 | 8.925 | 8.645 |
| Feb 7, 2025 | 8.680 | -0.315 | -3.50% | 8.995 | 9.015 | 8.680 |
| Feb 6, 2025 | 9.035 | 0.020 | 0.22% | 9.015 | 9.315 | 8.845 |
| Feb 5, 2025 | 8.970 | 0.645 | 7.75% | 8.325 | 8.990 | 8.325 |
| Feb 4, 2025 | 8.295 | -0.010 | -0.12% | 8.305 | 8.405 | 8.090 |
| Feb 3, 2025 | 8.350 | 0.065 | 0.78% | 8.285 | 8.520 | 8.215 |
| Jan 31, 2025 | 8.680 | 0.150 | 1.76% | 8.530 | 8.690 | 8.405 |
| Jan 30, 2025 | 8.520 | 0.435 | 5.38% | 8.085 | 8.540 | 8.075 |
| Jan 29, 2025 | 8.080 | -0.040 | -0.49% | 8.120 | 8.205 | 7.990 |
| Jan 28, 2025 | 8.120 | 0.035 | 0.43% | 8.085 | 8.470 | 8.060 |
| Jan 27, 2025 | 8.240 | 0.200 | 2.49% | 8.040 | 8.295 | 7.875 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Evotec Company profile
About Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Evotec SE revenues increased 20% to EUR431M. Net income increased from EUR5.8M to EUR247M. Revenues reflect EVT Execute segment increase of 22% to EUR329M, EVT Innovate segment increase of 36% to EUR101.9M, United States segment increase of 32% to EUR142.9M, Others segment increase of 30% to EUR47.5M, United Kingdom segment increase of 8% to EUR47.2M.
| Industry: | Biotechnology & Medical Research (NEC) |
Essener Bogen 7
HAMBURG
HAMBURG 22419
DE
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com